Jeeyun Lee
Clinical trials sponsored by Jeeyun Lee, explained in plain language.
-
New hope for hard-to-treat stomach cancer: drug combo shows promise
Disease control Recruiting nowThis study tests a combination of two targeted drugs, trastuzumab deruxtecan (T-DXd) and afatinib, in people with advanced HER2-low stomach cancer that has not responded to prior treatments. About 61 adults will take part to see if the combination is safe and can shrink tumors or…
Phase: PHASE1, PHASE2 • Sponsor: Jeeyun Lee • Aim: Disease control
Last updated May 15, 2026 11:59 UTC
-
New hope for stomach cancer patients with MET gene amplification?
Disease control Recruiting nowThis study tests a combination of two drugs, savolitinib and durvalumab, in people with advanced stomach cancer that has a specific genetic change called MET amplification. The goal is to see if this treatment can slow down the cancer after standard chemotherapy has stopped worki…
Phase: PHASE2 • Sponsor: Jeeyun Lee • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New hope for advanced stomach cancer: targeted drug combo trial launches
Disease control Recruiting nowThis study tests whether combining targeted therapies (Trastuzumab Deruxtecan and Capecitabine, with or without Rilvegostomig) before and after surgery can help people with a certain type of advanced stomach cancer (HER2-positive) that cannot be removed right away. About 50 adult…
Phase: PHASE2 • Sponsor: Jeeyun Lee • Aim: Disease control
Last updated May 13, 2026 16:02 UTC